IMV Inc IMVIQ

Upcoming Updates

[Hideaway]

We are scheduled to receive a couple of updates by end of the month.One for the phase 2 basket trials and another re the ovarian cancer submission to FDA for phase 2 clinical study protocol.
I hope that our expectations will be met but timeliness has been an issue in the past.
The shares have not exhibited much confidence in IMV.Hope for the best.
Board is awful quiet.Anyone have some encouraging thoughts?

[Biotech010]

the bladder trial data is EXCITING they say....but we need sales from the DPX platform. Give the first one free access and make money from the sales. The CEO needs to bring fantasy in the stock 

[alphaseeking001]

I honestly don't know what to think about the company right now.  While I'm relieved that management changes have been and are being made, we need to see rapid progress in the clinical programs going forward from here.  Also, where is the new CEO going to be coming from?  I'm surprised they haven't announced a permanent hire yet.  I'm assuming this is tax

[Hideaway]

Seems a bit to early for tax loss selling but maybe.My impression is that investors are getting weary of this stock and things could get worse if they miss the updates timelines. If we don't get updated in the next 15 to 18 days any subsequent positive news would be somewhat negated by Xmas.I believe it was a Wells Fargo report that suggested a few weeks ago that the bladder cancer results